Department of Civil and Environmental Engineering and Institute of Construction and Environmental Engineering, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea
Auto-generated profile, based on publicly available information
Jong Kwon Choe
Department of Civil and Environmental Engineering and Institute of Construction and Environmental Engineering, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea
Per- and polyfluoroalkyl substances (PFAS) are widely detected environmental contaminants, and there is a great need for development of sensor technologies for rapid and continuous monitoring of PFAS. In this study, we have developed fluorescence based aptasensor that can possibly monitor perfluorooctanoic acid (PFOA) in water with limit of detection (LOD) of 0.17 μM. This is first to report the successful isolation of PFAS binding ssDNA aptamers. The obtained aptamer selectively binds PFOA with dissociation constant (KD) of 5.5 μM. Specific aptamer binding sites to PFOA were identified and the length of the fluorinated carbons was a key binding factor rather than the functional group. The aptamer binding to structurally similar PFAS compounds (i.e., perfluorocarboxylic acids and perfluorosulfonic acids with 4-8 carbon chains) was also investigated; the aptamer KD values were 6.5 and 3.3 μM for perfluoroheptanoic acid and perfluorohexanesulfonic acid, respectively, while other analogs did not bind to the aptamer. The presence of major inorganic ions and dissolved organic matter had negligible influences on the aptamer performance (<14% at a 10 mM concentration), and the aptamer performance was also robust in real wastewater effluent conditions, with a KD of 7.4 μM for PFOA. Fluorescence-based aptasensor developed in this study is adequate in monitoring PFOA levels in water contaminated with the accident spills and heavy usage of fire-fighting foams near the industrial sites and military bases. More importantly, the study opens up new capability of aptasensors to efficiently monitor the trace amount of various PFAS compounds and other fluorinated alternatives in natural and engineered water environments.
1 August 2020 in Applied Catalysis B: Environment and Energy
Recently, an increasing number of pharmaceutical compounds has become fluorinated. Owing to their pharmacological efficacy, the use of these fluorinated pharmaceuticals continues to grow, and they constitute 20% of the drugs on the current market. However, only a few studies have investigated the fate and transformation of these emerging contaminants in natural and engineered aquatic environments. In the present study, the H2-based reductive transformation of three fluorinated pharmaceutical compounds (levofloxacin, sitagliptin, and fluoxetine) were investigated using alumina-supported monometallic and bimetallic catalysts of the Pt-group noble metals (i.e., Ru, Rh, Pd, and Pt) under ambient temperature and pressure conditions. Degradation of all three compounds was observed with catalytic reactivity ranging from 4.0 × 10-3 to 2.14 × 102 L/(min·gcat), in which fluoxetine generally showed the highest reactivity, followed by sitagliptin and levofloxacin. The fluorination yields and transformation products were characterized for each fluorinated compound and three different degradation mechanisms were elucidated: 1) hydrodefluorination of C-F bond to CH bond, 2) hydrogenation of aromatic ring, and 3) reductive cleavage of CO bond from phenyl ether. Toxicity assessment using Aliivibrio fischeri showed there were no significant changes in toxicity over levofloxacin and sitagliptin degradation, suggesting the formation of no highly toxic by-products during catalytic reduction. For fluoxetine, an increased toxicity was observed during its degradation while ECOSAR-predicted toxicity values of all identified intermediates were lower than that of fluoxetine, suggesting the formation of unidentified secondary by-products that contribute to the overall toxicity. The study showed that catalytic reduction is a promising remediation process for treating and defluorinating the fluorinated pharmaceutical compounds.
12 May 2014 in The Journal of Physical Chemistry C